1.Granerod, J, Crowcroft, NS. The epidemiology of acute encephalitis. Neuropsychological Rehabilitation 2007; 17: 406–428.
2.Rivers, TM. Viruses and Koch's postulates. Journal of Bacteriology 1937; 33: 1–12.
3.Burtis, CA, Ashwood, ER. Fundamentals of Molecular Diagnostics. Michigan, USA: Saunders Elsevier, 2007.
4.Ward, KN, et al. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Archives of Diseases of Childhood 2005; 90: 619–623.
5.Johnson, RT. The virology of demyelinating disease. Annals of Neurology 1994; 36: S54–S60.
6.Sejvar, JJ, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25: 5771–5792.
7.Young, NP, Weinshenker, BG, Lucchinetti, CF. Acute disseminated encephalomyelitis: current understanding and controversies. Seminars in Neurology 2008; 28: 84–94.
8.Dalmau, J, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 2008; 7: 1091–1098.
9.Vincent, A, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701–712.
10.Vincent, A, Bien, CG. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurology 2008; 7: 1074–1075.
11.Tunkel, AR, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008; 47: 303–327.
12.Bloch, KC, Glaser, CA. Diagnostic approaches for patients with suspected encephalitis. Current Infectious Disease Report 2007; 9: 315–322.
13.Glaser, CA, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clinical Infectious Diseases 2006; 43: 1565–1577.
14.Granerod, J, et al. The trials and tribulations of implementing a multi-centre study of encephalitis in England. Clinical Medicine 2007; 7: 646–647.
15.Mailles, A, Stahl, JP,Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clinical Infectious Diseases 2009; 49: 1838–1847.
16.Yousry, TA, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. New England Journal of Medicine 2006; 354: 924–933.
17.McArthur, JC, Brew, BJ, Nath, A. Neurological complications of HIV infection. Lancet Neurology 2005; 4: 543–555.
18.Ward, KN, et al. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. Journal of Clinical Microbiology 2007; 45: 1298–1304.
19.Kolski, H, et al. Etiology of acute childhood encephalitis at the hospital for sick children, Toronto, 1994–1995. Clinical Infectious Diseases 1997; 26: 398–409.
20.Nicolosi, A, et al. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950–1981. Journal of Infectious Diseases 1986; 154: 399–408.
21.Rantala, H, Uhari, M. Occurrence of childhood encephalitis: a population-based study. Pediatric Infectious Diseases Journal 1989; 8: 426–430.
22.Visvesvara, GS, Moura, H, Schuster, FL. Pathogenic and opportunistic free-livingamoebae: Acanthamoeba spp., Balamuthiamandrillaris. Naegleria fowleri, and Sappinia diploidea. FEMS Immunology and Medical Microbiology 2007; 45: 1–26.
23.Hansen, K, Lebech, AM. The clinical and epidemiological profile of lyme neuroborreliosis in Denmark 1985–1990: A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992; 115: 399–424.
24.Halperin, JJ. Nervous system Lyme disease. Infectious Disease Clinics of North America 2008; 22: 261–274.
25.Halperin, JJ, et al. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996; 46: 619–627.
26.Kristoferitsch, W. Neurological manifestations of Lyme borreliosis: clinical definition and differential diagnosis. Scandinavian Journal of Infectious Diseases 1991; 77: 64–73.
27.Cooke, RPD, Beeching, NJ. Neurobrucellosis in the UK. Journal of Infection 2009; 58: 88–89.
28.Julander, I, et al. Polymerase chain reaction for diagnosis of cerebral toxoplasmosis in cerebrospinal fluid in HIV-positive patients. Scandinavian Journal of Infectious Diseases 2001; 33: 538–541.
29.DeBiasi, RL, Tyler, KL. Molecular methods for diagnosis of viral encephalitis. Clinical Microbiological Reviews 2004; 17: 903–925.
30.Cinque, P, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. Journal of Neurology, Neurosurgery & Psychiatry 1996; 61: 339–345.
31.Ljungman, P, Singh, N. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. Journal of Clinical Virology 2006; 37 (Suppl. 1): S87–91.
32.Solomon, T, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bulletin of the World Health Organisation 2008; 86: 178–186.
33.Du Pasquier, RA, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003; 61: 775–782.
34.Wuthrich, C, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Annals of Neurology 2009; 65: 742–748.
35.Pecorari, M, et al. First human case of Usutu virus neuroinvasive infection, Italy, August–September 2009. Eurosurveillance 2009; 14: 19446.
36.Monteyne, P, et al. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis. Journal of Medical Virology 1997; 53: 324–331.
37.Krupp, LB, et al. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7–S12.
38.Pohl, D, et al. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. European Journal of Pediatrics 2007; 166: 405–412.
39.Leake, JAD, et al. Acute disseminated encephalomyelitis in childhood: Epidemiologic, clinical and laboratory features. Pediatric Infectious Disease Journal 2004; 23: 756–764.
40.Schwartz, S, et al. Acute disseminated encephalomyelitis: a follow up study of 40 adult patients. Neurology 2001; 56: 1313–1318.
41.Tenembaum, S, et al. Acute disseminated encephalomyelitis. Neurology 2007; 68: S23–S36.
42.Polman, CH, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Annals of Neurology 2005; 58: 840–846.
43.Johnson, RT. Postinfectious demyelinating diseases. In: Viral Infections of the Nervous System. Phildelphia: Lippincott-Raven, 1998, pp. 181–210.
44.Odaka, M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003; 126: 2279–2290.